Glucometabolic-Related Genes as Diagnostic Biomarkers and Therapeutic Targets for Alzheimer’s Disease and Type 2 Diabetes Mellitus: A Bioinformatics Analysis
Background. Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) are two widespread chronic disorders characterized by shared risk factors and molecular pathways. Glucose metabolism, pivotal for cellular homeostasis and energy supply, plays a critical role in these diseases. Its disturbance...
Saved in:
Main Authors: | Shuo Liu, He Chen, Xiao-Dong He, Xiao-Ou Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Neurology Research International |
Online Access: | http://dx.doi.org/10.1155/2024/5200222 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic Disorders
by: Zhengxia Mao, et al.
Published: (2022-01-01) -
Identification of therapeutic targets for Alzheimer’s Disease Treatment using bioinformatics and machine learning
by: ZhanQiang Xie, et al.
Published: (2025-01-01) -
Bioinformatic analysis of ferroptosis related biomarkers and potential therapeutic targets in vitiligo
by: Linli Liu, et al.
Published: (2025-01-01) -
Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease
by: Tian Meng, et al.
Published: (2025-02-01) -
Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
by: Hua-xiong Zhang, et al.
Published: (2025-02-01)